"ESR Australia is paying a speculated price of over $45 million for a Coolaroo industrial investment with immediate development upside.
The 8.2 hectare property, 2-50 Glenelg Street, was offloaded by Palla Pharma, which outlaid $8.145m in 2014."
An outlay of $8.145 then booking a gain of around $20 million. Looks like this company is better at property investing.
PAL Price at posting:
29.0¢ Sentiment: None Disclosure: Held
